...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.
【24h】

Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.

机译:与健康对照组相比,晚期胃肠道癌患者白细胞中二氢嘧啶脱氢酶mRNA表达的昼夜变化和血清皮质醇水平。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: The activity of dihydropyrimidine dehydrogenase (DPD) - the rate-limiting enzyme in fluorouracil (5-FU) catabolism - has been reported to vary according to the time of day. On the basis of this data, so-called chronomodulated chemotherapy regimens with variable-rate infusions of 5-FU have been investigated in the treatment of advanced colorectal cancer. Recent results suggest lower toxicity of 5-FU by chronomodulated application. However, the pattern of circadian DPD activity levels have been shown to vary considerably. METHODS: We, therefore, studied the circadian changes in mRNA expression of DPD in leukocytes of ten patients with advanced gastrointestinal carcinomas prior to chronomodulated 5-FU-based salvage therapy and in 5five healthy controls. Simultaneously, we measured serum cortisol levels (SCL) to evaluate the endogenous circadian hormone rhythm. RESULTS: SCL displayed a consistent circadian rhythm with the mean peak value of serum cortisol at 8 a.m. and the mean trough value at 11 p.m. both in patients and in controls. However, mean minimum-maximum serum cortisol differences of SCL were significantly lower in patients compared to controls. In the 5fivehealthy controls, a trend towards a circadian rhythm of DPD mRNA expression was observed with the peak of expression at 5 a.m. which was significantly different from the trough at 2 p.m. ( P<0.005 Mann-Whitney-Wilcoxon test). When each control was studied separately, only two individuals showed circadian variations that could be fitted to a cosine wave ( P=0.001, P=0.014, Cosinor analysis). In contrast, DPD mRNA expression in patients with advanced gastrointestinal carcinomas did not demonstrate any consistent circadian rhythm. Pairwise comparisons of groups of DPD mRNA levels at different times of the day did not show significant differences. CONCLUSIONS: In conclusion, our analysis of DPD mRNA expression in leukocytes from healthy controls demonstrates first evidence for a circadian DPD mRNA expression periodicity. In patients with advanced gastrointestinal carcinomas, however, this rhythm seems to be disturbed although circadian endogenous cortisol secretion pattern is maintained.
机译:目的:据报道,二氢嘧啶脱氢酶(DPD)的活性是氟尿嘧啶(5-FU)分解代谢中的限速酶,其活性随一天中的时间而变化。基于该数据,已经研究了使用5-FU可变速率输注的所谓同步化疗方案,用于治疗晚期大肠癌。最近的结果表明,通过计时应用可降低5-FU的毒性。但是,昼夜节律DPD活性水平的模式已显示出很大的差异。方法:因此,我们研究了10例基于5-FU的抢救疗法之前的晚期胃肠道癌患者和5例健康对照者白细胞中DPD mRNA表达的昼夜变化。同时,我们测量了血清皮质醇水平(SCL)以评估内源性昼夜节律激素的节律。结果:SCL显示出一致的昼夜节律,血清皮质醇的平均峰值在上午8点,平均谷值在下午11点。无论是患者还是对照组。但是,与对照组相比,SCL患者的血清SCL的最小-最大-最大平均差异显着降低。在5个健康对照组中,观察到DPD mRNA表达具有昼夜节律的趋势,其表达峰值在上午5点与下午2点的谷明显不同。 (P <0.005曼-惠特尼-威尔科森检验)。当分别研究每个对照时,只有两个个体显示出可以适应余弦波的昼夜节律变化(P = 0.001,P = 0.014,Cosinor分析)。相反,晚期胃肠道癌患者中DPD mRNA的表达未显示出任何一致的昼夜节律。在一天的不同时间,两组DPD mRNA水平的成对比较未显示明显差异。结论:总而言之,我们对来自健康对照组的白细胞中DPD mRNA表达的分析证明了昼夜节律DPD mRNA表达周期的初步证据。然而,在晚期胃肠道癌患者中,尽管维持了昼夜节律的内源性皮质醇分泌模式,但这种节律似乎受到了干扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号